Product Reimbursement Assistance
Jazz Pharmaceuticals offers support and guidance on reimbursement through our Patient Affairs area to patients and providers for our chronic, patient-administered products, as we understand the challenges you may be facing in obtaining your product and/or insurance coverage. Patient Assistance Programs Jazz Pharmaceuticals currently provides Patient Assistance Programs on Xyrem for U.S. patients who are uninsured and/or underinsured, through the National Organization of Rare Disorders, Inc. (NORD), a non-profit organization dedicated to the identification, treatment and cure of rare ?orphan diseases." Please contact the XYREM success program for more information (1-866-XYREM88). Xyrem? (sodium oxybate) oral solution: Reimbursement assistance is available through the Xyrem Success Program? for registered patients. Please call 1-866-XYREM88 (1-866-997-3688) or visit the www.xyrem.com website for more information.

Our Mission
- Improve patients' lives
- Develop valuable products in psychiatry and neurology
- Always keep patients firmly in mind
Our Inspiration
- Addressing poorly understood conditions and underserved patients
- Improving patient care and developing valuable programs for physicians and patients
News
06/30/2010 | Press ReleaseJazz Pharmaceuticals Announces Completion of Refinancing of its 15% Senior Secured Notes Due June 2011 With Closing of $50 Million Term Loan Due June 2013
06/24/2010 | Press Release
Jazz Pharmaceuticals' JZP-6 to be Reviewed at a Joint Meeting of the FDA's Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee on August 20, 2010
06/07/2010 | Press Release
Paul L. Berns Joins Jazz Pharmaceuticals' Board of Directors